Latest Breaking News On - போஃபா பத்திரங்கள் இந்தியா - Page 1 : comparemela.com

Nifty to correct to 15,000 in short-term: BofA Securities - The Hindu BusinessLine

Nifty to correct to 15,000 in short-term: BofA Securities - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Research analystBofa securities indiaAmish shahBofa securites indiaBofa securitiesஆராய்ச்சி ஆய்வாளர்போஃபா பத்திரங்கள் இந்தியாஅமிஷ் ஷாபோஃபா பத்திரங்கள்

Bain Capital-backed Emcure Pharmaceuticals files DRHP for IPO with Sebi

Bain Capital-backed Emcure Pharmaceuticals files DRHP for IPO with Sebi

Sunil mehtaSatish mehtaCapital marketsCredit suisse securities india privateGlobal coEmcure pharmaceuticalsAxis capitalJm financialExchange board of indiaBofa securities indiaPharmaceuticals limitedDraft red hearing prospectusExchange boardBain capital backed emcureBain capitalCapital limited

ipo: Emcure Pharma files draft paper for Rs 4,000 cr IPO

Emcure claims to be an R&D driven company with a differentiated product portfolio that includes orals, injectables and biologics, as well as an mRNA platform through which it is currently developing a COVID-19 vaccine, which has enabled it to reach a range of target markets across over 70 countries with a strong presence in Europe and Canada.

Global coEmcure pharmaceuticals onEmcure pharmaceuticalsBain capitalBofa securities indiaSuisse securitiesGlobal co ordinatorsBook running lead managersBook running lead managerJm financialEmcure pharmaEquity investorCredit suisse securitiesஉலகளாவிய இணைபைன் மூலதனம்போஃபா பத்திரங்கள் இந்தியா

Bain-backed Emcure Pharmaceuticals eyes $672 mln IPO - source

India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, which a source with direct knowledge of the matter said could be worth up to 50 billion rupees ($671.89 million).

New delhiAditi shahChris thomasShivani singhShounak dasguptaSubhranshu sahuThomson reuters trust principlesMerck co incGlenmark life sciencesDevyani internationalIndia emcure pharmaceuticalsEmcure pharmaceuticalsYum brandBain capitalGennova biopharmaceuticalsWindlas biotech

Emcure Pharma files DRHP for Rs 1,100 crore IPO

The IPO will include a fresh issue of equity shares aggregating up to Rs 1,100 crore and an offer for sale aggregating up to 18,168,356 equity shares from the promoters

Sunil mehtaSatish mehtaCapital marketsCredit suisse securities india privateGlobal coEmcure pharmaceuticalsMedplus health servicesAxis capitalJm financialExchange board of indiaBofa securities indiaPune based emcure pharmaceuticals limitedDraft red herring prospectusExchange boardBain capitalCapital limited